SPONSOR
University Hospital Tuebingen
Total Trials
12
Recruiting
12
Phases
Phase 2, Phase 3, Phase 1
Conditions studied: Acute Respiratory Distress SyndromeMajor Depressive DisorderPARKINSON DISEASE (Disorder)Congenital Heart Disease (CHD)Gynecological MalignanciesCervical CancerEndometrial CancerOvarian CancerVulvar CancerPostpartum Depression (PPD)
University Hospital Tuebingen is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Acute Respiratory Distress Syndrome, Major Depressive Disorder, PARKINSON DISEASE (Disorder), Congenital Heart Disease (CHD).
The trial portfolio spans Phase 2, Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital Tuebingen
How many clinical trials has University Hospital Tuebingen sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by University Hospital Tuebingen, of which 12 are actively recruiting participants. These trials cover conditions including Acute Respiratory Distress Syndrome, Major Depressive Disorder, PARKINSON DISEASE (Disorder). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital Tuebingen research focus on?
University Hospital Tuebingen clinical trials span Acute Respiratory Distress Syndrome, Major Depressive Disorder, PARKINSON DISEASE (Disorder), Congenital Heart Disease (CHD), Gynecological Malignancies, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital Tuebingen clinical trial?
To participate in a University Hospital Tuebingen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital Tuebingen trials with current recruitment status updated daily.
Clinical Trials by University Hospital Tuebingen
NCT04208126
Recruiting
Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial)
Acute Respiratory Distress Syndrome
NCT06410599 Phase 2
Recruiting
Pharmacologic Treatment Augmentation in Chronic Depression
Major Depressive Disorder
NCT07151378 Phase 3
Recruiting
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
PARKINSON DISEASE (Disorder)
NCT06845371
Recruiting
MELODY Registry Follow-Up Study
Congenital Heart Disease (CHD)
NCT05914974
Recruiting
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Gynecological Malignancies
NCT06682689
Recruiting
Investigation of TVNS Administration on Postpartum Mental Health
Postpartum Depression (PPD)
NCT06385288
Recruiting
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Soft Tissue Sarcoma Adult
NCT04878666
Recruiting
Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy
Breast Cancer
NCT02338167
Recruiting
Praegnant Breast Cancer: Early/Advanced/Metastatic
Advanced/Metastatic Breast Cancer
NCT03503149
Recruiting
Molecular Tumor Board at the Center for Personalized Medicine Tübingen
Advanced Cancer
NCT04270578
Recruiting
Gestational Diabetes
Gestational Diabetes
NCT05112549 Phase 1
Recruiting
Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
Leptomeningeal Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology